Could not find the file: /1424/1/Oncology Fact Sheet Nr.117.pdf
The file you are trying to access may be related to this item:
Rothschedl, E. and Wolf, S. (2023): Olaparib (Lynparza®) in combination with abiraterone and prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Update April 2023. Oncology Fact Sheet Nr. 117.
If you reached this page by following a link within the repository, please contact the Repository of AIHTA GmbH administration. Otherwise, please check that you have typed the URL in correctly, or contact the person or site that supplied you with this URL.